The purpose of this HIPAA and U.S. Privacy Policy ("Policy") is to define (and outline) Pandora S9, Inc., trading as Diagnostics Your Way (together, "DYYW") obligations as it relates to compliance with HIPAA (defined below) and other applicable United States ("U.S.") Data Protection Laws (defined below).
DXYW is committed to protecting the privacy, integrity, and security of those who entrust us with their Covered Data (defined below) that the company Processes (as defined below) in all aspects of its business worldwide. This Policy aligns to DXYW’s data protection and information security policy framework (the "Framework"), which includes DXYW’s policies, procedures, and documentation that outline DXYW’s strategy for compliance with data privacy and security requirements.
As an organization, that operates in the United States and provides certain Services (defined below), that may require the collection, use, and disclosure of Covered Data, DXYW has adopted this Policy, as part of its Framework requirements to ensure it adequately protects its Clients and Individuals (both defined below) Covered Data and appropriately complies with applicable U.S. Data Protection Laws. This includes adherence to the following applicable U.S. Data Protection Laws, including but not limited to:
This Policy applies to all Employees (as defined below), and applicable Suppliers (defined below) who may, during their business relationship with DXYW process Covered Data. Furthermore, this Policy applies from the time Covered Data is received and continues through the Processing activity, until the Covered Data us no longer required, returned, or deleted, in accordance with Framework and applicable contractual requirements.
Term | Definition |
---|---|
Authorization | A detailed document where specific PHI uses and disclosures are explained in full. When signing an Authorization, an Individual (defined below) gives consent to have their health information used or disclosed for the reasons stated in the Authorization. |
Business Associate (“BA”) | A person or entity that performs Covered Functions (defined below) or activities that involve the use or disclosure of PHI, including ePHI, on behalf of a CE (defined below). |
Business Associate Agreement (“BAA”) | A written arrangement that specifies a CE and BA’s responsibilities related to PHI use and disclosure, including requirements to safeguard PHI, in accordance with the Security Rule (defined below). |
Client | Entities that have engaged DXYW for Services under a written agreement, e.g., master services agreement. |
Consumer Health Data | As defined under the MHMDA, means any Personal Data (defined below) that are linked or reasonably linkable to an Individual and identifies an Individual’s past, present, or future physical or mental health status, including without limitation: use or purchase of a medication; efforts to obtain health supplies or services; biometric data; geofencing data; and data that identifies an Individual seeking healthcare services, among others. |
Covered Data | Means, in any form or format, any information that may directly or indirectly identify an Individual (defined below). This includes, without limitation, Personal Data, Sensitive Personal Data, PHI, Personal Information, Personally Identifiable Information (“PII”), and Consumer Health Data (all terms defined herein) including similar terms under, or otherwise governed, regulated, or protected by applicable U.S. Data Protection Laws. |
Covered Entity (“CE”) | A CE is a healthcare provider, health plan, payer, clearing house, or any other entity that Processes health data electronically in support of treatment, payment, or healthcare operations. |
Covered Function | Means any function, the performance of which makes the performer a health plan, a healthcare provider, or a healthcare clearinghouse, as defined under HIPAA. |
Data Minimization | Means the act of limiting the amount of Covered Data collected, stored, and processed to what are minimally necessary. |
Data Subject Rights Requests (“DSRRs”) | Requests that may be submitted by Individuals when exercising certain privacy rights afforded to them under applicable U.S. Data Protection Laws. |
Document Classification Chart (“Chart”) | Means the chart in Appendix A to this Policy, which outlines the classification criteria for how DXYW classifies its data risk categories, data types, associated data examples, best practices in how to safeguard such information, and authorization requirements that may be needed to release applicable data types in accordance with Framework requirements. |
Employees | Means a current, or former individual(s), who’s paid a salary (or wages) evidenced through an employment agreement, or W-2 arrangement, to support a DXYW job function, as outlined in an individual’s job description. |
HIV/AIDS Status | An Individual’s human immunodeficiency virus (“HIV”) and acquired immune deficiency syndrome (“AIDS”) positive or negative test result. |
Incident | A privacy and security event, or unauthorized disclosure(s) of Covered Data including: any potential breaches of security which may lead to accidental or unlawful destruction, loss, alteration, unauthorized disclosure of, or access to Covered Data transmitted, stored, or otherwise Processed. This includes without limitation: “Data Breach,” as defined under CCPA/CPRA and a “Breach,” as defined under HIPAA. For clarification purposes, where applicable U.S. Data Protection Laws are silent on defining an ‘Incident’ (e.g., MHMDA), the definition provided herein will apply. |
Individual | The person who is the subject of the Covered Data and includes a person who is a personal representative, i.e., a person has the authority to act on behalf of an individual who is an adult or an emancipated minor in making decisions related to the person’s healthcare or legal rights. |
Lawful Basis | A lawful (or legal) basis which allows for Personal Data – or Sensitive Personal Data – Processing. |
Opt-in | Means direct marketing, including email messages, SMS, telephone, or other forms of direct electronic communication may only be sent to recipients who have given their prior consent. |
Opt-out | Means an Individual who has requested discontinuation of direct marketing, for any reason, and DXYW must comply with such request. |
Personal Data | Data that are not PHI, as defined under HIPAA but are information that may directly or indirectly identify an Individual including (without limitation) personal data, personal information, personally identifiable information (“PII”), or Consumer Health Data, as defined under applicable U.S. Data Protection Laws.
It shall also include Personal Data Processed from current, past, and prospective Employees, Service User(s), healthcare providers, Clients, and Suppliers (as defined below) and their respective staff located within the United States. As outlined further in the Chart, Personal Data may also be referred to as “Confidential” or “Highly Confidential” depending on which data category (e.g., patient) and data types (e.g., health data, business contact information) are relevant. Personal Data may include data that are pseudonymized (i.e., masks data by replacing identifying information with artificial identifiers, e.g., patient ID). Personal Data DOES NOT include data that has been anonymized or de-identified, i.e., direct, or indirect personal identifiers have been removed, thus eliminating any ability to re-identify an Individual, Client, or Subprocessor (defined below). |
Privacy Rule | A set of national (U.S.) standards for the protection of certain health information. The Privacy Rule addresses the use and disclosure of Individuals’ health information (or PHI) by organizations subject to the Privacy Rule (i.e., CEs), as well as standards for Individuals’ privacy rights to understand and control how their health information is used. |
Process(es)(ed)(ing) | Any operation (or set of operations) which is performed on Covered Data such as: handling; collection; recording; organization structuring; storage; adaptation or alteration; retrieval; consultation; use; disclosure by transmission; dissemination or otherwise making available; alignment or combination; restriction; erasure; or destruction, as defined under applicable U.S. Data Protection Laws. |
Protected Health Information (“PHI”) |
Means any PII that appears in medical records (as well as conversations) between healthcare staff (such as doctors and nurses) regarding a patient’s treatment. It also includes billing information and any information that could be used to identify an Individual in a company’s health insurance records. PHI also includes “ePHI” which are electronic protected health information that are created, stored, transmitted, or received in any electronic format or media.
PHI DOES NOT include data that have been anonymized or de-identified, i.e., direct or indirect personal identifiers have been removed, thus eliminating any ability to re-identify an Individual. |
Records of Processing Activity(ies) (“ROPAs”) | An internal record that contains the information of required Covered Data Processing activities (carried out by DXYW) for its Services and support of applicable business activities and operations. ROPAs may also be used to support a DSRR. |
Regulated Entity | Means any legal entity as defined under the MHMDA that: (a) conducts business in Washington state (U.S.) or produces or provides products or services that are targeted to consumers in Washington; and (b) alone or jointly with others, determines the purpose and means of collecting, Processing, sharing, or selling of Consumer Health Data. |
Regulator(s) | Applicable regulatory authorities including (but not limited to) the U.S. Department of Health and Human Services (“HHS”), Office for Civil Rights (“OCR”), U.S State Attorney Generals, and the Federal Trade Commission (“FTC”) that oversee the enforcement of U.S. Data Protection Laws. |
Secretary | Means the Secretary of the HHS, or any other officer (or employee) thereof, to whom the authority involved has been delegated. |
Security Rule | National standards that specify a series of administrative, technical, and physical security measures for CEs, and Bas, to use to ensure the confidentiality, integrity, and availability of PHI. |
Sensitive Personal Data |
Special categories of Personal Data, which include information on an Individual’s biometric characteristics; genetic data; religious or philosophical beliefs; racial or ethnic origin; medical health (including HIV/AIDS Status); sex life or sexual orientation; political opinions; financial accounts, individual location tracking; trade union memberships; and any Personal Data of a minor under the age of 16.
Processing Sensitive Personal Data may require a specific purpose, sufficient necessity, explicit consent, and stricter protective measures as defined under applicable U.S. Data Protection Laws. |
Service(s) | Services contracted under DXYW Client master services agreements, or direct to Individuals, including distribution and diagnostics of sexual health testing kits for at home use. |
Service User | An Individual using the Services (i.e., sexual health testing) and to which PHI may be collected or Processed. |
Subprocessor | An authorized third-party engaged by DXYW to carry out Processing of Covered Data on its behalf. |
Supplier(s) | An external product (e.g., off-the-shelf application, system, or hardware), or service provider, for DXYW, including without limitation: vendors; suppliers; Subprocessors; subcontractors/contractors; consultants; and any other third-party providing a product (or service) to the company. |
Training | ARequired annual training for Employees, and other Suppliers, where applicable, which includes review of applicable compliance training policies and procedures, including without limitation: privacy and security; quality management; and other applicable job-related policies and procedures. |
Role | Responsibilities |
---|---|
Business Operations | Responsible for, in conjunction with DP and IT/Security, fulfilling required DSRRs, where applicable. |
Data Privacy (“DP”) | Responsible for creating and administering the Framework (as defined within the Privacy Policy), ensuring processes and controls are operational, performing legal review of applicable privacy and security contractual terms, and ensuring DXYW’s compliance with applicable U.S. Data Protection Laws. |
IT/Security | Responsible for designing, developing, implementing, and monitoring controls to safeguard Covered Data and mitigate potential Incidents, and ensure compliance with Framework requirements. IT/Security are also responsible for collaborating with DP on any Covered Data Incidents (where needed) and with other key stakeholders, where applicable. |
Legal | Responsible for assisting with applicable legal, compliance, and regulatory requirements, including collaborating with Data Privacy, IT/Security, QC, and any other stakeholders needed to ensure appropriate Framework implementation and compliance. Legal is also responsible for overseeing and supporting contract creation and review. |
DXYW Executive Team | The executive team is responsible for overseeing and supporting the roles and responsibilities outlined in this Section and Policy. |
Quality Compliance (“QC”) | Responsible for overseeing documentation, Training, and as applicable, corrective and preventative actions (“CAPAs”) in relation to privacy and security matters, where required. QC also aids in DXYW’s relevant aspects of DXYW’s Supplier due diligence, and related processes, to ensure Subprocessor requirements are maintained and audited, and ensure data privacy and security processes and controls are operating as designed and properly implemented. |
DXYW’s compliance with U.S. Data Protection Laws will depend on the Covered Functions and Services it performs, its relationship to applicable Individuals, and the parties that it contracts with under applicable master services agreements. This includes, as follows:
1. Where DXYW is solely performing laboratory services and is not conducting a HIPAA Covered Function, DXYW does not qualify as a Covered Entity, but will be considered an indirect healthcare provider, which is allowed to exchange PHI, and ePHI, with other Covered Entities, without having to enter into a BAA or obtain an Individual’s consent, so long as such exchange is related to treatment, payment, or healthcare operations.
2. For additional administrative Services performed by DXYW, contracted with applicable Clients (CE), DXYW shall qualify as a BA when transmitting any PHI, and ePHI, in an electronic form, in connection with a Covered Function. e.g., administrative functions that fall outside laboratory services such as managing a portal/website for Client.
3. Where onward transfers of applicable PHI, by DXYW, are made in performance of related business activities, operations, or Services, DXYW entities (including its parent company or other U.S. subsidiaries), such entity(ies) may be considered a Subprocessor. Where such transfers take place, all such entities shall be subject to this Policy, and adhere to the company’s “International Data Sharing, Transfer, and Processing Agreement,” including the applicable BAA therein; or
4. Where DXYW is otherwise Processing Covered Data, including providing Services direct to Individuals (or consumers) or performing other corporate activities that are not associated with a Covered Function, or under a BAA DXYW shall ensure its use and disclosure (or Processing) of Covered Data are managed, in accordance with applicable requirements under HIPAA (such as the Security Rule) and other applicable U.S. Data Protection Laws (i.e., CCPA, MHMDA, etc.).
Where DXYW Employees, and Suppliers, Process Covered Data, they must do so, in accordance with Framework obligations, applicable U.S. Data Protection Laws, and the following principles:
1. Lawful Basis: DXYW shall ensure that where required, Processing of Covered Data are based on a Lawful Basis, which may include consent, to fulfill a contract, a legal obligation, a vital or public interest, other legitimate interest, or other basis, as required under applicable U.S. Data Protection Laws. The Lawful basis shall be captured within DXYW’s Records of Processing Activities, in accordance with Section 5.11 below.
2. Limitation(s) on Uses or Disclosures: DXYW shall ensure, Covered Data Processed in support of applicable Services, are for specified, explicit, and legitimate purposes and not further Processed in a manner that are incompatible with those purposes; further Processing for archiving purposes in the public interest, scientific or historical research purposes, or statistical purposes shall not be considered incompatible with the initial purpose, in accordance with applicable U.S. Data Protection Law requirements and this Policy.
3. Sensitive Personal Data: Where DXYW Processes Sensitive Personal Data, it shall ensure such Processing adheres to applicable U.S. Data Protection Laws and individuals are informed about how their Sensitive Personal Data are Processed, in accordance with Section 5.3 below and shall allow Individuals to limit the use of their Sensitive Personal Data, in accordance with Section 5.4. (Individuals Rights) below.
4. Data Minimization Principle – “Minimum Necessary:” DXYW shall ensure Covered Data Processed by DXYW Employees and Suppliers (where applicable) are Processed only to perform applicable corporate business activities, operations, and Services. DXYW shall ensure that only the minimum amount of Covered Data is Processed, and such Processing is done in accordance with Framework requirements, this Policy, and applicable requirements under U.S. Data Protection Laws (including HIPAA).
5. Accuracy Principle: DXYW shall ensure Covered Data that are Processed in support of applicable Services are accurate, complete, kept-up-to-date, and appropriate for use; where not accurate, reasonable steps will be taken to ensure that such Covered Data are erased or rectified (without delay), having regard to the purposes for which they are Processed, in accordance with Individuals’ Rights described in Section 5.4 below.
6. Storage Limitation: In accordance with Data Minimization requirements and Framework requirements, Covered Data shall only be retained for no longer than what are minimally necessary for the purposes for which they are Processed, and as consented to, or to meet regulatory requirements. For PHI, retention shall be up to six (6) years where required by HIPAA.
7. Data Privacy and Security-by-Design. DXYW shall assess its Processing activities to ensure it incorporates data privacy protections into the design of information systems, products, and services to prevent Incidents and protect Individuals’ privacy by proactively incorporating data privacy and security safeguards into company systems/applications and processes.
8. Data Security Principle: In accordance with Section 5.7 below, DXYW shall ensure Covered Data are Processed in a manner that ensures such data are safeguarded by implementing appropriate administrative, technical, and physical safeguards, as required under the Security Rule, including without limitation: protection against unauthorized or unlawful Processing; and protection against accidental loss, destruction, or damage. Such security controls shall consider: 1) industry standards; 2) the costs of implementation; 3) the nature, scope, context, and Processing purposes; and 4) the risk of varying likelihood and severity for Individuals’ rights and freedoms of natural persons.
9. Sale of Data. For CCPA purposes, and other applicable U.S. Data Protection Laws, DXYW DOES NOT “sell” Personal Data or PII. Should the company’s business model change and requires the sale of such data, the company shall ensure no Covered Data, is sold without the appropriate Individual consent and without providing Individuals the ability to Opt-out of such sale.
10. Accountability Principle: Where required, DXYW shall ensure that it is able to demonstrate compliance with applicable U.S. Data Protection Laws.
11. Consent. Where consent is the basis for Processing of Covered Data, DXYW shall ensure any required consent under applicable U.S. Data Protection Laws is: 1) freely and explicitly given; 2) specific, informed, and unambiguous; and 3) Individuals are allowed to withdraw consent (as is applicable to the Services), in accordance with Section 5.4 below.
1. Responsible Parties. This Policy designates DXYW’s Data Privacy office, and IT/Security office (with support from DXYW representatives from Legal, Quality Compliance, and Business Operational teams, as well as external third-party privacy and security experts) as the representatives, as required by HIPAA and applicable U.S. Data Protection Laws, who will serve as DXYW’s privacy and security officers and who are the person(s) responsible for the development and implementation of DXYW’s privacy and security policies and procedures and with whom other Employees should consult when issues arise concerning the use, disclosure, or other matters relating to the privacy of Individuals’ Covered Data and records.
2. Compliance Team. DXYW shall ensure it maintains a structured privacy and security compliance team, which addresses compliance and standards; data privacy and protection; legal and regulatory compliance matters; business continuity and disaster recovery; communications and operations security management; physical security; systems acquisition, development and maintenance; Supplier management; configuration and change management for software systems; incident response planning and management, including appropriate maintenance and monitoring and analysis of audit logs.
3. Confidentiality. Employees, and as applicable, Suppliers, with access to Covered Data, shall be bound to keep such information confidential and shall comply with DXYW Framework requirements, applicable data privacy and security policies and procedures, and confidentiality agreements as may be applicable.
4. Contracts. DXYW shall enter into appropriate contractual relationships with Covered Entities, Suppliers, Subprocessors, and other third parties as required to perform the Services, including Business Associate Agreements for Processing of PHI on behalf of Covered Entities and other applicable agreements (such as data processing agreements) for Processing of other Personal Data.
5. Data Classification. Covered Data shall be classified in accordance with its risk sensitivity level, as identified in the Chart. The Chart criteria applies to all Covered Data Processed by DXYW and provides guidelines for how such data are to be protected with the appropriate level of organizational and technical measures, as further outlined under Section 5.7 (Data Safeguards) below.
1. As standard, DXYW Clients (as the CEs) shall be required to obtain valid Authorization for the use and disclosure of PHI to DXYW for its Services, and shall ensure its practices align with those Authorizations, in accordance with this Section.
2. Where required, DXYW shall make available a notice of privacy practices (“Privacy Notice”), consistent with the Privacy Rule, applicable U.S. Data Protection Laws, and in accordance with the Framework requirements. This Privacy Notice shall be generally available at DXYW’s website at: www.dxyourway.com
3. Such Privacy Notice(s) shall provide adequate notice of applicable Processing (including uses and disclosures) of PHI (made by DXYW), and include at minimum, the following information:
4. Where Services are being provided directly to an Individual, such Privacy Notice(s) shall be provided to Individuals before the start of the Services and require the Individual to agree to the use and disclosures associated with the Services. Such Privacy Notice(s) shall include additional information, as required under applicable U.S. Data Protection Laws, including:
5. Where DXYW is considered a Regulated Entity under MHMDA, DXYW shall also maintain a “Consumer Health Data Privacy Policy,” as required under the law. This shall include, the information outlined above and the following:
1. In accordance with applicable U.S. Data Protection Laws and the Privacy Rule, Individuals shall have the right to exercise their rights and submit DSRRs. Such rights shall include, without limitation:
2. DSRRs may be submitted in accordance with the methods described under <
Requests shall be fulfilled within one (1) month of receipt or as otherwise required under applicable U.S. Data Protection Laws, including:
4. Fees. As standard, DXYW does not charge a fee for handling routine DSRR requests. However, DXYW reserves the right to charge reasonable administrative fees if requests are complex in nature or unduly burdensome, subject to applicable U.S. Data Protection Law fee restrictions. For HIPAA requests, i.e., accounting of disclosures, such requests will be free of charge within a single twelve (12) month period. For multiple requests within a twelve (12) month period, DXYW reserves the right to charge a reasonable, cost-based fee for each subsequent request (by the same Individual) made within the applicable twelve (12) month period; provided that, the Individual is informed of the fee in advance, and the Individual has an opportunity to withdraw, or modify, their request to avoid or reduce fees.
5. DXYW shall not retaliate against an Individual for exercising rights provided by the applicable U.S. Data Protection Laws (including the Privacy Rule), for assisting in an investigation by the HHS or another appropriate authority, or for opposing an act or practice that the person believes in good faith violated DXYW’s privacy practices or applicable U.S. Data Protection Laws.
6. Receipt of Unauthorized Covered Data If DXYW receives Covered Data that it was not authorized to receive, e.g., PHI that were not part of an Authorization, BAA, or outside of the minimum data required for a particular Processing activity, such matters will be handled, in accordance with the Information Security and Risk Management Procedure, to ensure appropriate remediation, such as deletion or redaction of such unauthorized Covered Data, where technically feasible and relevant.
1. DXYW shall Process Covered Data in accordance with the principals and protections, as defined within this Policy, Framework requirements, and applicable requirements under U.S. Data Protection Laws.
In accordance with HIPAA, where DXYW is Processing PHI on behalf of a CE, the following shall apply:
3. Where DXYW provides Services directly to an Individual, DXYW shall not quality as a CE or BA, but shall provide Notice to Individuals that is consistent with HIPAA and in accordance with Section 5.4 of this Policy. It shall use, and disclose, PHI only for those explicit purposes, or as provided in valid Authorizations, in accordance with applicable U.S. Data Protection Laws.
4. Where DXYW discloses PHI to an authorized recipient (i.e., a Subprocessor), it shall ensure the recipient of any PHI must provide DXYW reasonable assurances that the PHI will be held confidentially, subject to applicable confidentiality, data privacy and security obligations under a master services agreement (or BAA, where applicable) and used or further disclosed only as permitted, required by law, or for the purpose of the disclosure, in accordance with Section 5.10 (Supplier Management) of this Policy.
5. Data Aggregation: Prevents, where applicable, in its capacity as a BA, may aggregate PHI with the PHI of other CEs that DXYW possesses, for the purpose of providing data analyses related to the healthcare operations of each of its CEs, so long as such data aggregation practices apply de-identification to any PHI.
6. De-Identification (or Anonymization): DXYW may de-identify Covered Data, so long as such de-identification practices align to applicable HIPAA standards, or other applicable U.S. Data Protection Laws, ensuring applicable Individual identifiers are removed. Such practices shall be performed in accordance with Framework requirements or as otherwise required under applicable U.S. Data Protection Laws.
7. Subprocessors: DXYW will share PHI only with authorized Suppliers/Subprocessors who are contractually bound to terms at least as restrictive as DXYW’s Framework obligations, quality procedures, instructions, and written agreements, in accordance with Section 5.10 of this Policy.
1. DXYW shall implement and maintain data protection and security measures, as required under applicable U.S. Data Protection Laws (including the Security Rule under HIPAA) that include administrative, technical, and physical safeguards designed to ensure the confidentiality, reliability, integrity, and availability of Covered Data and any systems, facilities, or software that are used, accessed, or supported in connection with Services and Processing of Covered Data. Such safeguards shall be in accordance with Framework requirements, as outlined in this Section 5.7.
2. Administrative Safeguards
3. Physical Security. Where physical locations hold, and Process, Covered Data, as required to perform the Services, DXYW shall ensure:
1. DXYW shall complete or provide ROPAs, in accordance with applicable U.S. Data Protection Laws and shall include the following information (where required):
2. If ROPAs are not readily available, DXYW shall ensure they are produced by the applicable stakeholders within an appropriate timeframe to meet any regulatory obligations or fulfill requests from an applicable Client or Individuals
Name of Classification | Description | Impact | Examples | Permitted/Restricted Activities |
---|---|---|---|---|
Public | Public data is unrestricted and meant for public consumption. | Confidentiality is of no particular significance to this information. | Web pages; Publicity and marketing materials; Organisational Accreditation information; and Public contact details. | No specific restrictions |
General | Daily work products used and shared throughout the organisation and with relevant clients, suppliers or subcontractors. | The inappropriate disclosure of this information could:
|
Organisational Policies; Products; Client deliverables; and Meeting minutes. | This information should be freely shared within the organisation. It should not be made available to anyone outside the organisation without permission or authorisation and should not be assumed to be common knowledge. |
Confidential | Data which is crucial to the success of the organisation or which is subject to legal restrictions or is held under a contractual or common law duty of confidentiality. | The inappropriate disclosure of this information could:
|
Personal and special category data (e.g. names and addresses); Some meeting minutes; Commercially confidential information (e.g. contracts, contractual negotiations, etc.); Financial information; Security information; Incident information; | This information must:
|
Highly Confidential | The most critical data to the organisation which should be shared only with named recipients. | The result of this information becoming available to anyone outside the group specified could have the same effect as ‘Confidential’ information but the list of those who may be made privy to the information is very restricted and should not ordinarily be changed. | Some meeting minutes; Some financial information; Some security information; Some incident information; Legal advice; |
|